Acticca-01: For Investigators

ACTICCA-1: Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma. A randomized, multidisciplinary, multinational AIO/DGAV/DGVS phase III trial.

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. Return both documents to the Trial Office.

Trial Documents

Links to the current protocol, Patient Information Sheet(s), Informed Consent Form(s) are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the ACTICCA-1 Trial Office.

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control List. 

Investigator Site File Version Control Lists

Pharmacy File Version Control Lists


Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

Case Report Form





Other Trial Documents


There are currently no publications for this trial.

Contact Details

UK National Coordinator
John Bridgewater

Overall German Trial Coordinator
Dr Alexander Stein
University Medical Center Hamburg-Eppendorf

UK Trial Coordinator
Jennika Mistry

UK Trial Management Team Leader
Sarah Bowden

eCRF access problems:

UK Trial Monitor
Monitoring Team, CRCTU, University of Birmingham

Overall German Trial Statistician
Eik Vettorazzi
University Medical Center Hamburg-Eppendorf

Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
B15 2TT

UK Enquiries
Telephone: +44 (0)121 414 3973
erman Email Contact:

Trial Entry
Please enrol patients via

Serious Adverse Event Reporting
Fax:  +49-40-524719-222

University of Birmingham
B15 2TT